With the region experiencing yet another surge in cases of COVID-19, the Mobile Integrated Health (MIH) program is participating in an innovative clinical trial that brings a much talked about drug to treat COVID-19 (remdesivir) to patients at home, instead of at the hospital.

The $2.7 million location is an exciting new chapter in South Shore Medical Center's 57-year history of providing primary care to the South Shore.